Moderna (MRNA) Change in Taxes (2021 - 2024)
Moderna (MRNA) reported Change in Taxes of -$2.0 million for Q3 2024, down 122.22% year-over-year from $9.0 million in Q4 2023, and up 95.56% quarter-over-quarter from -$45.0 million in Q2 2024.
Moderna (MRNA) Change in Taxes (2021 - 2024) Analysis & Trends
Moderna (MRNA) has 4 years of Change in Taxes data on file, last reported at -$2.0 million in Q3 2024.
- Change in Taxes for Q3 2024 came in at -$2.0 million, down 122.22% year-over-year; the trailing twelve-month figure through Sep 2024 was -$51.0 million (down 410.0% YoY), and the FY2023 annual result was $15.0 million, up 101.81% from the prior year.
- Change in Taxes advanced to -$2.0 million in Q3 2024 per MRNA's latest filing, from -$45.0 million in the prior quarter.
- Over five years, Change in Taxes peaked at $716.0 million in Q1 2022 and troughed at -$1.2 billion in Q2 2022.
- A 4-year average of $333333.3 and a median of $7.0 million in 2023 frame the typical range for Change in Taxes.
- On a YoY basis, Change in Taxes climbed as much as 695.56% in 2022 and fell as far as 533.1% in 2022.
- A 4-year view of Change in Taxes shows it stood at $311.0 million in 2021, then slumped by 105.79% to -$18.0 million in 2022, then surged by 138.89% to $7.0 million in 2023, then sank by 128.57% to -$2.0 million in 2024.
- Business Quant data shows MRNA's Change in Taxes at -$2.0 million in Q3 2024, -$45.0 million in Q2 2024, and -$11.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -45.00 Mn |
| Jun 30, 2024 | -45.00 Mn |
| Mar 31, 2024 | -11.00 Mn |
| Mar 31, 2024 | -11.00 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | -19.00 Mn |
| Jun 30, 2023 | -19.00 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | -18.00 Mn |
| Dec 31, 2022 | -18.00 Mn |
| Sep 30, 2022 | -283.00 Mn |
| Sep 30, 2022 | -283.00 Mn |
| Jun 30, 2022 | -1.24 Bn |
| Jun 30, 2022 | -1.24 Bn |